{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:33:56Z","timestamp":1790922836483,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health Research NIHR, UK)","award":["16\/136\/46"],"award-info":[{"award-number":["16\/136\/46"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T008822\/1"],"award-info":[{"award-number":["MR\/T008822\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>By August 2021, the COVID-19 pandemic has been less severe in sub-Saharan Africa than elsewhere. In Malawi, there have been three subsequent epidemic waves. We therefore aimed to describe the dynamics of SARS-CoV-2 exposure in Malawi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured the seroprevalence of anti-SARS-CoV-2 antibodies amongst randomly selected blood transfusion donor sera in Malawi from January 2020 to July 2021 using a cross-sectional study design. In a subset, we also assessed in vitro neutralisation against the original variant (D614G WT) and the Beta variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5085 samples were selected from the blood donor database, of which 4075 (80.1%) were aged 20\u201349\u2009years. Of the total, 1401 were seropositive. After adjustment for assay characteristics and applying population weights, seropositivity reached peaks in October 2020 (18.5%) and May 2021 (64.9%) reflecting the first two epidemic waves. Unlike the first wave, both urban and rural areas had high seropositivity in the second wave, Balaka (rural, 66.2%, April 2021), Blantyre (urban, 75.6%, May 2021), Lilongwe (urban, 78.0%, May 2021), and Mzuzu (urban, 74.6%, April 2021). Blantyre and Mzuzu also show indications of the start of a third pandemic wave with seroprevalence picking up again in July 2021 (Blantyre, 81.7%; Mzuzu, 71.0%). More first wave sera showed in vitro neutralisation activity against the original variant (78% [7\/9]) than the beta variant (22% [2\/9]), while more second wave sera showed neutralisation activity against the beta variant (75% [12\/16]) than the original variant (63% [10\/16]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings confirm extensive SARS-CoV-2 exposure in Malawi over two epidemic waves with likely poor cross-protection to reinfection from the first on the second wave. The dynamics of SARS-CoV-2 exposure will therefore need to be taken into account in the formulation of the COVID-19 vaccination policy in Malawi and across the region. Future studies should use an adequate sample size for the assessment of neutralisation activity across a panel of SARS-CoV-2 variants of concern\/interest to estimate community immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-02187-y","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T20:02:18Z","timestamp":1637265738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021"],"prefix":"10.1186","volume":"19","author":[{"given":"Jonathan","family":"Mandolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquline","family":"Msefula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Y. R.","family":"Henrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comfort","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brewster","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey","family":"Samon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandeka","family":"Moyo-Gwete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanele","family":"Makhado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thopisang","family":"Motlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonkululeko","family":"Mzindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newton","family":"Kalata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamson S.","family":"Muula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Nsamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Likaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thom","family":"Mfune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridon","family":"Mbaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Swarthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3195-2210","authenticated-orcid":false,"given":"Kondwani C.","family":"Jambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"2187_CR1","unstructured":"COVID-19 case tracker [https:\/\/coronavirus.jhu.edu\/map.html.]"},{"key":"2187_CR2","doi-asserted-by":"crossref","unstructured":"Kaye AD, Okeagu CN, Pham AD, Silva RA, Hurley JJ, Arron BL, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol. 2021;35(3): 293\u2013306.","DOI":"10.1016\/j.bpa.2020.11.009"},{"issue":"6502","key":"2187_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.abc0035","volume":"69","author":"PGT Walker","year":"2020","unstructured":"Walker PGT, Whittaker C, Watson OJ, Baguelin M, Winskill P, Hamlet A, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 2020;69(6502):413\u201322.","journal-title":"Science"},{"issue":"1","key":"2187_CR4","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1038\/s41467-021-23267-w","volume":"12","author":"B Morton","year":"2021","unstructured":"Morton B, Barnes KG, Anscombe C, Jere K, Matambo P, Mandolo J, et al. Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa. Nat Commun. 2021;12(1):3554.","journal-title":"Nat Commun"},{"key":"2187_CR5","doi-asserted-by":"crossref","unstructured":"Chibwana M, Jere K, Kamng\u2019ona R, Mandolo J, Katunga-Phiri V, Tembo D, et al. High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi [version 2; peer review: 2 approved]. Wellcome Open Res. 2020;5(199):1\u201315.","DOI":"10.12688\/wellcomeopenres.16188.1"},{"issue":"1","key":"2187_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4269\/ajtmh.20-1235","volume":"104","author":"O Olayanju","year":"2021","unstructured":"Olayanju O, Bamidele O, Edem F, Eseile B, Amoo A, Nwaokenye J, et al. SARS-CoV-2 seropositivity in asymptomatic frontline health workers in Ibadan, Nigeria. Am J Trop Med Hyg. 2021;104(1):91\u20134.","journal-title":"Am J Trop Med Hyg"},{"issue":"6524","key":"2187_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.abe1916","volume":"371","author":"S Uyoga","year":"2021","unstructured":"Uyoga S, Adetifa IMO, Karanja HK, Nyagwange J, Tuju J, Wanjiku P, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science. 2021;371(6524):79\u201382.","journal-title":"Science"},{"key":"2187_CR8","doi-asserted-by":"publisher","first-page":"103419","DOI":"10.1016\/j.ebiom.2021.103419","volume":"68","author":"M Schoenhals","year":"2021","unstructured":"Schoenhals M, Rabenindrina N, Rakotondramanga JM, Dussart P, Randremanana R, Heraud JM, et al. SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 epidemic. EBioMedicine. 2021;68:103419.","journal-title":"EBioMedicine"},{"issue":"3","key":"2187_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4269\/ajtmh.17-0905","volume":"99","author":"A Ho","year":"2018","unstructured":"Ho A, Mallewa J, Peterson I, SanJoaquin M, Garg S, Bar-Zeev N, et al. Epidemiology of severe acute respiratory illness and risk factors for influenza infection and clinical severity among adults in Malawi, 2011-2013. Am J Trop Med Hyg. 2018;99(3):772\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"2187_CR10","unstructured":"Judge in Malawi blocks government lockdown, at least temporarily [https:\/\/www.voanews.com\/covid-19-pandemic\/judge-malawi-blocks-government-lockdown-least-temporarily]"},{"key":"2187_CR11","unstructured":"Malawi President announces plans to reopen schools in September [https:\/\/www.voanews.com\/covid-19-pandemic\/malawi-president-announces-plans-reopen-schools-september]"},{"key":"2187_CR12","unstructured":"Malawi to lift COVID-19 international air travel restrictions from September [https:\/\/www.businesslive.co.za\/bd\/world\/africa\/2020-08-27-malawi-to-lift-covid-19-international-air-travel-restrictions-from-september\/]"},{"issue":"2","key":"2187_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4314\/mmj.v31i2.3","volume":"31","author":"B M\u2019Baya","year":"2019","unstructured":"M\u2019Baya B, Jumbe V, Samuel V, M\u2019Bwana R, Mangani C. Seroprevalence and trends in transfusion transmissible infections among voluntary non-remunerated blood donors at the Malawi Blood Transfusion Service-a time trend study. Malawi Med J. 2019;31(2):118\u201325.","journal-title":"Malawi Med J"},{"key":"2187_CR14","volume-title":"Population and housing census","author":"NSO","year":"2009","unstructured":"NSO. Population and housing census. Malawi: Zomba: National Statistical Office; 2009."},{"key":"2187_CR15","unstructured":"WANTAI SARS-CoV-2 Ab ELISA [https:\/\/www.fda.gov\/media\/140929\/download]"},{"issue":"4","key":"2187_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","volume":"27","author":"CK Wibmer","year":"2021","unstructured":"Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021;27(4):622\u20135.","journal-title":"Nat Med"},{"issue":"4","key":"2187_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ije\/dyab049","volume":"50","author":"MYR Henrion","year":"2021","unstructured":"Henrion MYR. bootComb\u2014an R package to derive confidence intervals for combinations of independent parameter estimates. Int J Epidemiol. 2021, dyab049;50(4):1071\u20136.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2187_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1467-9868.00374","volume":"65","author":"SN Wood","year":"2003","unstructured":"Wood SN. Thin plate regression splines. J Royal Stat Soc. 2003;65(1):95\u2013114.","journal-title":"J Royal Stat Soc"},{"key":"2187_CR19","first-page":"22","volume-title":"National Statistics Office: National Statistics Office","author":"Government M","year":"2020","unstructured":"Government M. 2018 Malawi Population and Housing Census Population Projections 2018 \u2013 2050 report. In: National Statistics Office: National Statistics Office; 2020. p. 22\u20133."},{"key":"2187_CR20","first-page":"2005.2012.21257","volume":"2021","author":"E Wilkinson","year":"2021","unstructured":"Wilkinson E, Giovanetti M, Tegally H, San JE, Lessels R, Cuadros D, et al. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. medRxiv. 2021;2021:2005.2012.21257080.","journal-title":"medRxiv"},{"key":"2187_CR21","first-page":"2003.2006.43419","volume":"2021","author":"T Moyo-Gwete","year":"2021","unstructured":"Moyo-Gwete T, Madzivhandila M, Makhado Z, Ayres F, Mhlanga D, Oosthuysen B, et al. SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies. bioRxiv. 2021;2021:2003.2006.434193.","journal-title":"bioRxiv"},{"key":"2187_CR22","first-page":"233375","volume":"rs.3.rs","author":"W Sykes","year":"2021","unstructured":"Sykes W, Mhlanga L, Swanevelder R, Glatt TN, Grebe E, Coleman C, et al. Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Res Sq. 2021;rs.3.rs:233375.","journal-title":"Res Sq"},{"key":"2187_CR23","unstructured":"[https:\/\/www.voanews.com\/covid-19-pandemic\/malawi-mandates-quarantine-returnees-south-africa]"},{"issue":"8","key":"2187_CR24","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.cell.2021.02.033","volume":"184","author":"P Supasa","year":"2021","unstructured":"Supasa P, Zhou D, Dejnirattisai W, Liu C, Mentzer AJ, Ginn HM, et al. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021;184(8):2201\u20132211.e2207.","journal-title":"Cell"},{"issue":"7857","key":"2187_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","volume":"593","author":"S Cele","year":"2021","unstructured":"Cele S, Gazy I, Jackson L, Hwa S-H, Tegally H, Lustig G, et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature. 2021;593(7857):142\u20136.","journal-title":"Nature"},{"key":"2187_CR26","unstructured":"COVID-19 - MOH MALAWI [https:\/\/covid19.health.gov.mw\/]"},{"issue":"6","key":"2187_CR27","doi-asserted-by":"publisher","first-page":"100290","DOI":"10.1016\/j.xcrm.2021.100290","volume":"2","author":"SP Anand","year":"2021","unstructured":"Anand SP, Prevost J, Nayrac M, Beaudoin-Bussieres G, Benlarbi M, Gasser R, et al. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset. Cell Rep Med. 2021;2(6):100290.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2187_CR28","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1038\/s41467-020-18450-4","volume":"11","author":"AT Huang","year":"2020","unstructured":"Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun. 2020;11(1):4704.","journal-title":"Nat Commun"},{"key":"2187_CR29","first-page":"2007.2025.21261","volume":"2021","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Yassine HM, Benslimane FM, Al Khatib HA, et al. Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection. medRxiv. 2021;2021:2007.2025.21261093.","journal-title":"medRxiv"},{"key":"2187_CR30","first-page":"2005.2008.21256","volume":"2021","author":"S Havervall","year":"2021","unstructured":"Havervall S, Marking U, Greilert-Norin N, Ng H, Salomonsson A-C, Hellstr\u00f6m C, et al. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. medRxiv. 2021;2021:2005.2008.21256866.","journal-title":"medRxiv"},{"issue":"10279","key":"2187_CR31","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","volume":"397","author":"C Manisty","year":"2021","unstructured":"Manisty C, Otter AD, Treibel TA, McKnight \u00c1, Altmann DM, Brooks T, et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021;397(10279):1057\u20138.","journal-title":"Lancet"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02187-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02187-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02187-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T21:02:34Z","timestamp":1637269354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02187-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02187-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.18.21262207","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the College of Medicine (now Kamuzu University of Health Sciences) Research Ethics Committee (P.09\/20\/3123). At the time of donation, blood donors provide consent to draw blood for transfusion and for use in studies of public health importance. COVID-19 research qualifies as an activity of urgent public health importance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}